Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines, today announced interim data from a phase 1b study of ABX1100 ...

As FY25 results reveal a mixed year for Pfizer, the company is looking to turn its fortunes around with newly acquired Metsera obesity assets.

Exciting developments in mRNA vaccines, treatments for long covid and the safe use of artificial intelligence are just some ...

To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...

ETHealthworld.com brings latest serum institute of india news, views and updates from all top sources for the Indian Health industry.

The "Molecular Switch Targeting Therapies Market Landscape, Innovation Pipeline and Commercial Impact 2026" report has been added to ResearchAndMarkets.com's offering. The report is designed to give ...

ETHealthworld.com brings latest bharat biotech news, views and updates from all top sources for the Indian Health industry.

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...

益诺思长期聚焦创新药前沿赛道，持续投入研发资源，已搭建起具有国际竞争力的技术平台与全链条评价能力，公司建立了从毒理、药代到分子检测的完整方法体系，具备承接各类复杂剂型与创新项目的能力，致力于为生物医药创新提供系统性的解决方案。

The Convergence of mRNA Technology, Universal Vaccine Research, and Post-Pandemic Health Policies Creates a Trillion-Dollar ...

Akeso, Inc. (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled "Spotlight On: The Drugs That Will Shape 2026", providing an in-depth analysis ...